EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Increasing the utility of epidemiologic studies as key evidence in chemical risk assessment

Heather R Schaefer, Melissa J Vincent, Carol J Burns, Sabine S Lange

Toxicological Sciences · 01.02.2025 · 203 (2) · 166-170

DOI: 10.1093/toxsci/kfae134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 06.12.2024. Verfasst von Heather R Schaefer und 3 weiteren Autor:innen. Beteiligte Einrichtung: US Food and Drug Administration (FDA), College Park, MD 20740, United States. Hauptthemen laut MEDLINE: Epidemiologic Studies, Toxicology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: US Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Society of Toxicology 2024 meeting assembled risk assessors, epidemiologists, and toxicologists to discuss the utility of integrating epidemiologic data into the derivation of reference values. Advantages of the use of epidemiologic evidence include (i) human relevance; (ii) increased likelihood that exposure levels are relevant to risk assessment; and (iii) incorporation of uncertainties attributed to co-exposures or other population-based considerations. The workshop panelists discussed the challenges of incorporating epidemiologic evidence due to uncertain exposure measurements, confounding, heterogeneity, and inherent study design limitations. Capturing uncertainty is a critical step. In summary, epidemiologic evidence can be a valuable tool for risk analysis. This workshop brief captures constructive considerations from practitioners in the field that can increase the utility of epidemiologic studies in chemical risk assessment and harmonize the approach for use in dose-response assessment that will ultimately reduce uncertainty related to chemical exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidemiologic StudiesToxicologyRisk AssessmentHumansUncertaintyEnvironmental ExposureAnimals

Stichwörter der Autor:innen

chemical risk assessmentepidemiologic evidenceevidence-based methodstoxicological reference values

Autor:innen und Institutionen

  • US Food and Drug Administration (FDA), College Park, MD 20740, United States.
  • ToxStrategies, LLC, Asheville, NC 28801, United States.
  • Burns Epidemiology Consulting, LLC, Thompsonville, MI 49683, United States.
  • Texas Commission on Environmental Quality, Austin, TX 78753, United States.

Förderung

  • US Food and Drug Administration

Zitieren

APA

Schaefer, H. R., Vincent, M. J., Burns, C. J., & Lange, S. S. (2025). Increasing the utility of epidemiologic studies as key evidence in chemical risk assessment. Toxicological Sciences, 203(2), 166-170. https://doi.org/10.1093/toxsci/kfae134

Vancouver

Schaefer HR, Vincent MJ, Burns CJ, Lange SS. Increasing the utility of epidemiologic studies as key evidence in chemical risk assessment. Toxicological Sciences. 2025;203(2):166-170. doi:10.1093/toxsci/kfae134

BibTeX
@article{Schaefer2025,
  author = {Schaefer, Heather R and Vincent, Melissa J and Burns, Carol J and Lange, Sabine S},
  title = {Increasing the utility of epidemiologic studies as key evidence in chemical risk assessment},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {203},
  number = {2},
  pages = {166--170},
  doi = {10.1093/toxsci/kfae134}
}
Kostenlos starten →